Acting for several commercial banks in litigation cases arising from structure notes issued by Lehman Brothers Group.
Acting for a public company with operations both in Taiwan and China in a toxic torts case regarding a US$8 million claim in Taiwan. In this case, we successfully introduced an epidemiology theory, which had never been used in Taiwan in deciding causation in torts cases, into the court system.
Acting for the client’s management team in numerous litigation cases arising from a financial holding company attempting a hostile takeover of a government-owned financial holding company.
Acting for a government-owned company in a claim for invalidation of an arbitral award under CAA Rules in relation to a US$30 million claim on the grounds that the tribunal lacked the mandate to render the award.
Acting for a U.S. multilevel marketing company in Taiwan in filing a commercial arbitration case arising from a breach of confidentiality under a settlement agreement. The arbitration is held in Taiwan under CAA Rules, and the applicable law is Taiwanese law.
Acting for a Taiwanese government-owned company in conciliation proceedings for a construction dispute with a Korea-based multinational construction company regarding adjustment of the completion day and remedies arising from an EPC contract. The dispute is valued at US$6 million and the governing law was Taiwanese law.
Acting for an Indonesian company in defending against damage claims made by a Chinese government-owned company on the grounds of a breach of an EPC contract. The claim is valued at US$3 million. The arbitration was held in Beijing under CIETAC Arbitration Rules, and the governing law was Singapore law.
Acting for a Taiwan-based pharmaceutical company in defending an international arbitration case filed by its distributor with the Chamber of Commerce in Milan, Italy. The claim is valued at US$4 million. The arbitration was held in Milan under the rules of the Milan Chamber of Commerce. The applicable law is Italian law.
Acting for the Taiwan branch of a U.S. pharmaceutical company in relation to a US$10 million claim following the alleged wrongful termination of a distributorship agreement. The dispute was subject to Taiwanese law related to the issue of the jurisdiction of the tribunal to adjudicate disputes with respect to a terminated contract, the ability of a party to assert contractual rights of termination without knowledge of the existence of the contract, and a wide-ranging enquiry into the remoteness of damages claimed. The arbitration was held in Taiwan under ICC Rules.
Acting for a Taiwanese government-owned company in a construction dispute with a Japan-based multinational construction company. The dispute is valued at US$246 million.
Acting for a Taiwanese government-owned company in a dispute arising from a bidding process that complies with the Agreement on Government Procurement within the framework of the World Trade Organization. The dispute is valued at US$46 billion.
Acting as an arbitrator in an arbitration in relation to a contract dispute between a Taiwanese government-owned commercial bank and a multinational information technology company. The dispute is valued at US$4 million. The arbitration is held in Taiwan under CAA Rules.
Acting as the chair arbitrator in an arbitration in relation to an ISDA-related dispute between a multinational commercial bank and a multinational manufacturing company. The dispute is valued at US$1.7 million. The arbitration is held in Taiwan under CAA Rules.